<DOC>
	<DOCNO>NCT01083381</DOCNO>
	<brief_summary>In study want find whether MS14 - herbal drug- help Schizophrenia patient .</brief_summary>
	<brief_title>Is MS14 Helpful Schizophrenia ?</brief_title>
	<detailed_description>Schizophrenia chronic illness characterize disturbance cognition , affect behavior , bizarre aspect . It common disorder , prevalence 1 % . It equal prevalence sex although men manifest symptom earlier woman . [ 1 , 2 ] Individuals schizophrenia 2-3 fold increase mortality rate compare general population . This rate increase recent decade . [ 3 , 4 ] Most patient incapable maintain job relationship . About half attempt suicide , 10 % succeed . Most suicides occur early course illness . [ 1 ] Optimal management schizophrenia require psychological , social , occupational therapy . [ 2 ] There lot antipsychotic drug necessary treatment . Risperidone , atypical antipsychotic , approve Food Drug Administration treatment schizophrenia adolescent population adolescent population . [ 5 ] Although atypical antipsychotic agent improve outcomes schizophrenia , clinical potential remains limited patient ' nonadherence medication . [ 6 ] Some patient schizophrenia respond completely treatment experience partial improvement remain functionally impair . While medication find effective treatment `` positive '' symptom disease , treatment `` negative symptom '' schizophrenia ( include lack energy , motivation , emotion ) historically successful . [ 4 , 5 ] MS14 Iranian herbal-marine compound patent invention patent registration office Islamic Republic Iran ( : 29350 ) classify equivalent food observable adverse effect level ( NOAEL ) . [ 8 , 9 ] According analytic data compound contain many inorganic salt complex also trace element bromine ( Br ) , strontium ( Sr ) , vanadium ( V ) , titanium ( Ti ) , nickel ( Ni ) zinc ( Zn ) . [ 10 ] Safety MS14 confirm sub-acute toxicity study rat ( clinical , histopathological , hematological biochemical ) . [ 8 ] A study MS14 experimental allergic encephalomyelitis ( EAE ) model show oral treatment EAE mouse MS14 halt progression disease also attenuate inflammation CNS indicate herbal-marine compound anti-inflammatory effect [ 11 ] . Overall , alleviation clinical neurological symptom EAE mouse MS14 explain beneficial effect traditionally use MS14 MS patient , effect could also investigate group psychological neurological disease . Additionally , anecdotal unconfirmed report effectiveness MS14 patient schizophrenia . In regard , decide perform randomize placebo-controlled study effect MS14 schizophrenia , assess safety efficacy compound .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>No concurrent diseases Signing consent form either patient guardian Proved diagnosis schizophrenia SCID structure interview Exclusion criterion : Patients treatment resistance schizophrenia Recent resistance risperidone Contraindications MS14 risperidone administration Patients residual simple schizophrenia Age 65 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Schizophrenia treatment MS14 randomize clinical trial</keyword>
</DOC>